Stay updated on Pembrolizumab After Weekly Paclitaxel Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.

Latest updates to the Pembrolizumab After Weekly Paclitaxel Clinical Trial page
- Check3 days agoChange DetectedFooter revision label updated from v3.5.4 to v3.5.5, indicating a page version update. The change does not alter trial details, eligibility criteria, or results.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov page was updated to Completed with Results Posted, and new text describes the maintenance pembrolizumab approach after weekly paclitaxel in platinum-resistant ovarian cancer. It also notes the non-randomised phase II design, primary and secondary outcomes, and provides access to the protocol and statistical analysis plan.SummaryDifference3%

- Check25 days agoChange Detected- The page now shows a new revision tag indicating the latest release version (v3.5.4). This is a release-note style update and does not modify the study content or the information presented.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page’s footer revision/version number was updated from v3.5.2 to v3.5.3, reflecting a site/UI release rather than a change to the trial content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check67 days agoChange DetectedThe study record now shows 'Results Submitted' instead of 'No Results Posted'.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Weekly Paclitaxel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Weekly Paclitaxel Clinical Trial page.